Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease

FEMS Immunology and Medical Microbiology

Volumn 16, Issue 2, 1996, Pages 105-115

  Moran, Anthony P ^a   Prendergast, Martina M ^a   Appelmelk, Ben J ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Campylobacter jejuni; Guillain Barre syndrome; Haemophilus influenzae; Helicobacter pylori; lipopolysaccharide; molecular mimicry; Neisseria spp.

Indexed keywords

LIPOPOLYSACCHARIDE; OLIGOSACCHARIDE;

AUTOIMMUNITY; BACTERIAL INFECTION; BACTERIAL OUTER MEMBRANE; CAMPYLOBACTER JEJUNI; CONFERENCE PAPER; GUILLAIN BARRE SYNDROME; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEISSERIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ANIMALS; AUTOIMMUNITY; CARBOHYDRATE SEQUENCE; GLYCOLIPIDS; GLYCOSPHINGOLIPIDS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNE TOLERANCE; LIPOPOLYSACCHARIDES; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA;

EID: 0030540967     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(96)00072-7     Document Type: Conference Paper

References (94)

1. [1] Nikaido, H. and Vaara, M. (1987) Outer membrane. In: Escherichia coli and Salmonella typhimurium. Cellular and Molecular Biology, Vol. 1 (Neidhardt, F.C., Ed.), pp. 7-22. American Society for Microbiology, Washington, DC.
2. [2] Moran, A.P. (1994) Structure-bioactivity relationships of bacterial endotoxins. J. Toxicol. Toxin Rev. 14, 47-83.
3. [3] Rietschel, E.T., Brade, L., Holst, O., Kulshin, V.A., Lindner, B., Moran, A.P., Schade, U.F., Zähringer, U. and Brade, H. (1990) Molecular structure of bacterial endotoxin in relation to bioactivity. In: Endotoxin Research Series, Vol. 1. Cellular and Molecular Aspects of Endotoxin Reactions (Nowotny, A., Spitzer, J.J. and Ziegler, E.J., Eds.), pp. 15-32. Elsevier Science Publishers B.V., Amsterdam.
4. [4] Mandrell, R.E. and Apicella, M.A. (1993) Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187, 382-402.
5. [5] Nachamkin, I., Blaser, M.J. and Tompkins, L.S. (1992) Campylobacter jejuni: Current Status and Future Trends. American Society for Microbiology, Washington, DC.
6. [6] Marshall, B.J. and Warren, J.R. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i, 1311-1315.
7. [7] Rauws, E.A.J. and Tytgat, G.N.J. (1990) Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335, 1233-1235.
8. [8] Forman, D., Newell, D.G., Fullerton, F., Yarnell, J.W., Stacey, A.R., Wald, N. and Sitas, F. (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J. 302, 1302-1305.
9. [9] Moran, A.P., Helander, I.M. and Kosunen, T.U. (1992) Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol. 174, 1370-1377.
10. [10] Moran, A.P. (1995) Cell surface characteristics of Helicobacter pylori. FEMS Immunol. Med. Microbiol. 10, 271-280.
11. [11] Mandrell, R.E., Schneider, H., Apicella, M., Zollinger, W., Rice, P.A. and Griffiss (1986) Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect. Immun. 54, 63-69.
12. [12] Preston, M.A. and Penner, J.L. (1987) Structural and antigenic properties of lipopolysaccharides from serotype reference strains of Campylobacter jejuni. Infect. Immun. 55, 1806-1812.
13. [13] Moran, A.P. and Kosunen, T.U. (1989) Serological analysis of the heat-stable antigens involved in serotyping Campylobacter jejuni and Campylobacter coli. APMIS 97, 253-260.
14. [14] Jennings, H.J., Lugowski, C. and Ashton, F.E. (1983) The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis. Carbohydr. Res. 121, 233-241.
15. [15] Michon, F., Beurret, M., Gamian, A., Brisson, J.-R. and Jennings, H.J. (1990) Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis. J. Biol. Chem. 265, 7243-7247.
16. [16] Gamian, A., Beurret, M., Michon, F., Brisson, J.-R. and Jennings, J.H. (1992) Structure of the L2 lipopolysaccharides core oligosaccharides of Neisseria meningitidis. J. Biol. Chem. 267, 922-925.
17. [17] Di Fabio, J.L., Michon, F., Brisson, J.-R. and Jennings, H.J. (1990) Structure of the L1 and L6 core oligosaccharide epitopes of Neisseria meningitidis. Can. J. Chem. 68, 1029-1034.
18. [18] John, C.M., Griffiss, J.M., Apicella, M.A., Mandrell, R.E. and Gibson, B.W. (1991) The structural basis for pyocin-resistance in Neisseria gonorrhoeae lipooligosaccharides. J. Biol. Chem. 266, 19303-19311.
19. [19] Mandrell, R.E. (1992) Further antigenic similarities of Neisseria gonorrhoeae lipooligosaccharides and human glycosphingolipids. Infect. Immun. 60, 3017-3020.
20. [20] Yamasaki, R., Bacon, B.E., Nasholds, W., Schneider, H. and Griffiss, J.M. (1991) Structural determination of oligosaccharides derived from lipooligosaccharide of Neisseria gonorrhoeae F62 by chemical, enzymatic, and two-dimensional NMR methods. Biochemistry 30, 10566-10575.
21. [21] Borrelli, S., Roggen, E.L., Hendriksen, D., Jonasson, J., Ahmed, H.J., Pioy, P., Jansson, P.-E. and Lindberg, A.A. (1995) Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose. Infect. Immun. 63, 2665-2673.
22. [22] Schweda, E.K.H., Sundström, A.C., Eriksson, L.M., Jonasson, J.A. and Lindberg, A.A. (1994) Structural studies of the cell envelope lipopolysaccharides from Haemophilus ducreyi strains ITM 2665 and ITM 4747. J. Biol. Chem. 269, 12040-12048.
23. [23] Mandrell, R.E., McLaughlin, R., Kwaik, Y.A., Lesse, A., Yamasaki, R., Gibson, B., Spinola, S.M. and Apicella, M.A. (1992) Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. Infect. Immun. 60, 1322-1328.
24. [24] Gibson, B.W., Melaugh, W., Phillips, N.J., Apicella, M.A., Campagnari, A.A. and Griffiss, J.M. (1993) Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry. J. Bacteriol. 175, 2702-2712.
25. [25] Melaugh, W., Phillips, N.J., Campagnari, A.A., Tullius, M.V. and Gibson, B.W. (1994) Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms. Biochemistry 33, 13070-13078.
26. [26] Jann, B., Rodriguez, M.-L., Finke, A., Kröncke, K.-D. and Jann, K. (1991) Chemical characterization of E.coli capsules and analysis of their expression. In: FEMS Symposium, No. 51. Microbial Surface Components and Toxins in Relation to Pathogenesis (Ron, E.Z. and Rottem, S., Eds.), pp. 151-160. Plenum Press, New York.
27. k antigen as determined by a monoclonal antibody. J. Immunogen. 12, 213-220.
28. [28] Yurewicz, E.C., Matsuura, F. and Moghissi, K.S. (1982) Structural characterization of neutral oligosaccharides of human midcycle cervical mucin. J. Biol. Chem. 257, 2314-2322
29. [29] Ward, M.E., Watt, P.J. and Glynne, A.A. (1970) Gonococci in urethral exudates possess a virulence factor lost on subculture. Nature (London) 227, 382-384.
30. [30] Tan, E.L., Patel, P.V., Parsons, N.J., Martin, P.M.V. and Smith, H. (1986) Lipopolysaccharide alteration is associated with induced resistance of Neisseria gonorrhoeae to killing by human serum. J. Gen. Microbiol. 132, 1407-1413.
31. [31] Patel, P.V., Parsons, N.J., Andrade, J.R.C., Nairn, C.A., Tan, E.L., Glodner, M., Cole, J.A. and Smith, H. (1988) White blood cells including polymorphonuclear phagocytes contain a factor which induces gonococcal resistance to complement-mediated serum killing. FEMS Microbiol. Lett. 50, 173-176.
32. [32] Parsons, N.J., Andrade, J.R.C., Patel, P.V., Cole, J.A. and Smith, H. (1989) Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5′-monophospho-N-acetylneuraminic acid. Microb. Pathog. 7, 63-72.
33. [33] Mandrell, R.E., Lesse, A.J., Sugai, J.V., Shero, M., Griffiss, J.M., Cole, J.A., Parsons, N.J., Smith, H., Morse, S.A. and Apicella, M.A. (1990) In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J. Exp. Med. 171, 1649-1664.
34. [34] Frangipane, J.V. and Rest, R.F. (1993) Anaerobic growth and cytidine 5′-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoea. Infect. Immun. 61, 1657-1666.
35. [35] Mandrell, R.E., Kim, J.J., John, C.M., Gibson, B.W., Sugai, J.V., Apicella, M.A., Griffiss, J.M. and Yamasaki, R. (1991) Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J. Bacteriol. 173, 2823-2832.
36. [36] Pavliak, V., Brisson, J.-R., Michon, F., Uhrin, D. and Jennings, H.J. (1993) Structure of the sialylated L3 Lipopolysaccharide of Neisseria meningitidis. J. Biol. Chem. 268, 14146-14152.
37. [37] Ganguli, A., Zapata, G., Wallis, T., Reid, C., Boulnois, G., Vann, W.F. and Roberts, I.S. (1994) Molecular cloning and analysis of genes for sialic acid synthesis in Neisseria meningitidis group B and purification of the meningococcal CMP-NeuNAc synthetase enzyme. J. Bacteriol. 176, 4583-4589.
38. [38] Mandrell, R.E., Smith, H., Jarvis, G.A., Grifiss, J.M. and Cole, J.A. (1993) Detection and some properties of the sialyltransferase implicated in the sialylation of lipopolysaccharide of Neisseria gonorrhoeae. Microb. Pathog. 14, 307-313.
39. [39] de la Paz, H., Cooke, S.J. and Heckels, J.E. (1995) Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens. Microbiology 141, 913-920.
40. [40] Rest, R.F. and Frangipane, J.V. (1992) Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils. Infect. Immun. 60, 989-997.
41. [41] Wetzler, L.M., Barry, K., Blake, M.S. and Gotschlich, E.C. (1992) Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect. Immun. 60, 39-43.
42. [42] Meri, S. and Pangburn, M.K. (1990) Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87, 3982-3986.
43. [43] Mishu, B. and Blaser, M.J. (1993) Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin. Infect. Dis. 17, 104-108.
44. [44] Mishu, B., Ilyas, A.A., Koski, C.L., Vtiesendorp, Cook, S.D., Mithen, F.A. and Blaser, M.J. (1993) Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann. Intern. Med. 118, 947-953.
45. [45] Rees, J.H., Soudain, S.E., Gregson, N.A. and Hughes, R.A.C. (1995) Campylobacter jejuni infection and Guillain-Barré syndrome. New Engl. J. Med. 333, 1374-1379.
46. [46] Kuroki, S., Saida, T., Nukina, M. et al. (1993) Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33, 243-247.
47. [47] Yuki, N. and Tsujino, Y. (1995) Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Pediatr. 126, 162.
48. [48] Mishu, B., Ho, T.W., Li, C.Y., Gao, C.Y., Griffin, J.W., Ashury, A.K., Cornblath, D.R., Patton, C.M., McKhann, G.M. and Blaser, M.J. (1993) Guillain-Barré syndrome (GBS), acute motor axonal neuropathy and C. jejuni infection. Acta Gastro-Enterol. Belg. 56, Suppl., S9.
49. [49] Oomes, P.G., Jacobs, B.C., Hazenberg, M.P.H., Bänffer, J.R.J. and van der Meché, F.G.A. (1995) Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry. Ann. Neurol. 38, 170-175.
50. [50] Yuki, N., Taki, T., Takahashi, M., Saito, K., Yoshino, H., Tai, T., Handa, S. and Miyatake, T. (1994) Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann. Neurol. 36, 791-793.
51. 1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann. Neurol. 37, 260-264.
52. [52] van der Meché, F.G.A., Schmitz, P.I.M. and the Dutch Guillain-Barré Study Group (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. New Engl. J. Med. 326, 1123-1129.
53. 1 antibodies following Campylobacter enteritis. Neurology 40, 1900-1902.
54. [54] Schwerer, B., Neisser, A., Polt, R.J., Bernheimer, H. and Moran, A.P. (1995) Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome. J. Endotoxin Res. 2, 395-403.
55. [55] Figueras, A., Morales-Olivas, F.J., Capella, D., Palop, V., Laporte, J.R. (1992) Bovine gangliosides and acute motor polyneuropathy. Br. Med. J. 305, 1330-1331.
56. [56] Illa, I., Ortiz, N., Gallard, E., Juarez, C., Grau, J.M. and Dalakas, M.C. (1995) Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol. 38, 218-224.
57. [57] Waxman, S.G. (1995) Sodium channel blockade by antibodies: a new mechanism of neurological disease. Ann. Neurol. 37, 421-423.
58. M1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed. Res. 13, 451-453.
59. [59] Wirguin, I., Suturkova-Milosevic, L., Della-Latta, P., Fisher, T., Brown, R.H. and Latov, N. (1994) Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann. Neurol. 35, 698-703.
60. [60] Yuki, N., Taki, T., Takahashi, M., Saito, K., Tai, T., Miyatake, T. and Handa, S. (1994) Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect. Immun. 62, 2101-2103.
61. [61] Yuki, N., Taki, T., Inagaki, F., Kasama, T., Takahashi, M., Saito, K., Handa, S. and Miyatake, T. (1993) A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178, 1771-1775.
62. [62] Aspinall, G.O., McDonald, A.G., Pang, H., Kurjanczk, L.A. and Penner, J.L. (1994) Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33, 241-9.
63. [63] Moran, A.P. and O'Malley, D.T. (1995) Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barré syndrome. J. Endotoxin Res. 2, 233-235.
64. [64] Yuki, N., Handa, S., Tai, T., Takahashi, M., Saito, K., Tsujino, Y. and Taki, T. (1995) Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J. Neurol. Sci. 130, 112-116.
65. [65] Moran, A.P., Rietschel, E.T., Kosunen, T.U. and Zähringer, U. (1991) Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J. Bacteriol. 173, 618-626.
66. [66] Moran, A.P. (1995) Biological and serological characterization of Campylobacter jejuni lipopolysaccharides with deviating core and lipid A structures. FEMS Immunol. Med. Microbiol. 11, 121-130.
67. [67] Aspinall, G.O., McDonald, A.G., Raju, T.S., Pang, H., Moran, A.P. and Penner, J.L. (1993) Chemical structure of the core regions of Campylobacter jejuni serotypes O:1, O:4, and O:23 and O:36 lipopolysaccharides. Eur. J. Biochem. 213, 1017-27.
68. [68] Aspinall, G.O., McDonald, A., Raju, T.S., Pang, H., Kurjanczyk, L.A., Penner, J.L. and Moran, A.P. (1993) Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. Eur. J. Biochem. 213, 1029-1037.
69. [69] Aspinall, G.O., Lynch, C.M., Pang, H. Shaver, R.T. and Moran, A.P. (1995) Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide. Eur. J. Biochem. 231, 570-578.
70. [70] Aspinall, G.O., McDonald, A.G. and Pang, H. (1994) Lipopolysaccharides of Campylobacter jejuni O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33, 250-255.
71. [71] Yuki, N., Sato, S., Itoh, T. and Miyatake, T. (1991) HLA-B35 and acute axonal polyneuropathy following Campylobacter infection. Neurology 41, 1561-1563.
72. [72] Yuki, N. (1994) Pathogenesis of axonal Guillain-Barré syndrome: hypothesis. Muscle Nerve 17, 680-682.
73. [73] Aspinall, G.O., Monteiro, M.A., Moran, A.P. (1995) Chemical structures of lipopolysaccharides: a window on strain to strain variations in H. pylori. Gut 37 (Suppl. 1), A17.
74. [74] Moran, A.P. (1996) The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment. Pharmacol. Ther. 10, Suppl. 1, 39-50.
75. [75] Aspinall, G.O., Monteiro, M.A., Pang, H., Walsh, E.J. and Moran, A.P. (1994) O antigen chains in the lipopolysaccharide of Helicobacter pylori NCTC 11637. Carbohydr. Lett. 1, 151-156.
76. [76] Aspinall, G.O., Monteiro, M.A., Pang, H., Walsh, E.J. and Moran, A.P. (1996) Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 35, 2489-2497.
77. [77] Aspinall, G.O., Monteiro, M.A., Moran, A.P., Pang, H., Penner, J.L. and Shaver, R.T. (1995) Lipopolysaccharides from Helicobacter pylori. Prog. Clin. Biol. Res. 392, 93-101.
78. [78] Mills, S.D., Kurjanczyk, L.A. and Penner, J.L. (1992) Antigenicity of Helicobacter pylori lipopolysaccharides. Infect. Immun. 30, 3175-3180.
79. [79] Aspinall, G.O. and Monteiro, M.A. (1996) Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions. Biochemistry 35, 2498-2504.
80. [80] Simoons-Smit, I.M., Appelmelk, B.J., Verboom, T., Negrini, R., Penner, J.L., Aspinall, G.O., Moran, A.P., Fei Fei, S., Bi-shan, S., Rudnica, W., Savio, A. and De Graaff, J. (1996) Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide. J. Clin. Microbiol. 34, 2196-2200.
81. [81] Springer, G.F., Williamson, P. and Brandes, W.C. (1961) Blood group activity of gram-negative bacteria. J. Exp. Med. 113, 1077-1093.
82. [82] Sashkov, A.S., Vinogradov, E.V., Knirel, Y.A., Nifant'ev, N.E., Kochetkov, N.K., Dabrowski, J., Kholodkova, E.V. and Stanislavsky, E.S. (1993) Structure of the O-specific polysaccharide of Salmonella arizonae O:45. Carbohydr. Res. 241, 177-188.
83. x blood group antigens in human gastric carcinoma and in normal gastric tissue. Cancer Res. 49, 745-752.
84. [84] Chan, N.W.C., Stangier, K., Sherburne, R., Taylor, D.E., Zhang, Y., Dovichi, N.J. and Palcic, M.M. (1995) The biosynthesis of Lewis X in Helicobacter pylori. Glycobiology 5, 683-688.
85. [85] Appelmelk, B.J, Simoons-Smit, I., Negrini, R., Moran, A.P., Aspinall, G.O., Forte, J.G., De Vries, T., Quan, H., Verboom, T., Maaskant, J.J., Ghiara, P., Kuipers, E.J., Bloemena, E., Tadema, T.M., Townsend, R.R., Tyagarajan, K., Crothers, J.M., Monteiro, M.A., Savio, A. and De Graff, J. (1996) Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 64, 2031-2040.
86. [86] Negrini, R., Lisato, L., Zanella, I., Cavazzini, L., Gullini, S., Villanacci, V., Poiesi, C., Albertini, A. and Ghielmi, S. (1991) Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 101, 437-445.
87. [87] Sherburne, R. and Taylor, D.E. (1995) Helicobacter pylori expresses a complex surface carbohydrate. Lewis X. Infect. Immun. 63, 4564-4568.
88. [88] Kekki, M., Siurala, M., Varis, K., Sipponen, P., Sistonen, P. and Nevanlinna, H.R. (1987) Classification principles and genetics of chronic gastritis. Scand. J. Gastroenterol. 22 (Suppl. 141), 1-28.
89. [89] Siurala, M., Isokoski, M., Varis, K. and Kekki, M. (1968) Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand. J. Gastroenterol. 3, 211-223.
90. [90] Kekki, M., Villako, K., Tammi, A. and Siurala, M. (1977) Dynamics of antral and fundal gastritis in an Estonian rural population sample. Scand. J. Gastroenterol. 12, 321-4.
91. [91] Strickland, R.G. and Makay, I.R. (1973) A reappraisal of the nature and significance of chronic atrophic gastritis. Dig. Dis. 18, 426-440.
92. [92] Fan, X.G., Yahoob, J., Fan, X.J. and Keeling, P.W.N. (1996) Enhanced T-helper 2 lymphocyte responses: immune mechanism of Helicobacter pylori infection. Ir. J. Med. Sci. 165, 37-39.
93. + T-cell subsets. Proc. Natl. Acad. Sci. USA 91, 18-22.
94. [94] Mosmann, T.R. and Coffman, R.L. (1989) Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46, 111-147.